Waalre, The Netherlands, 10 February 2021 – IME Medical Electrospinning, a global leader in
electrospun medical devices, today announced that it has entered into a collaboration with Dutch
medical device company STENTiT, to join forces in the further development and production of
regenerative endovascular support grafts (see video). These resorbable fibrous implants hold the
promise to rebuild a new blood vessel inside the existing artery, by exploiting the natural healing
response of the body.
IME’s technological solutions enable the manufacturing of innovative devices like STENTiT’s
endovascular support grafts, which are aimed to mimic the natural human extracellular matrix for
implants in the human body in nanometer and micrometer format. Human cells rebuild these matrices
leading to new body tissue. This is in contrast to implants of traditional structures, which are seen as
foreign and therefore can lead to scar tissue formation or rejection phenomena.
STENTiT is an emerging player in the field of regenerative medical devices, offering a breakthrough
solution for cardiovascular interventions developing first-of-its-kind regenerative endovascular blood
vessel implants. Using a catheter-based approach, it provides the ability to restore the artery without
the need for an invasive surgical intervention. The aim is to ultimately restore the affected artery from
the inside-out to provide a life-lasting solution.
Bart Sanders, CEO of STENTiT, says:
“We are thrilled to join forces with IME Medical Electrospinning to further optimize our fibrillated
endovascular implants. IME is a highly innovative and leading company in the field of Medical
Electrospinning, for which I’m confident that together we will spur the development of a superior
and reproducible product, while getting STENTiT ready to scale.”
Judith Heikoop, CEO of IME Medical Electrospinning, adds:
“We are extremely proud to have been able to expand our collaborations with such a promising
company like STENTiT. IME Medical Electrospinning develops medical devices in close
collaboration with an ever-growing portfolio of customers and partners worldwide within the
industry, the scientific environment, hospitals and medical institutes. This collaboration is
testimony to our strategic goal to become a trusted partner worldwide in co-developing
electrospun medical devices that will cause a revolution in the industry and will enable tissue
rebuilding.”
IME has set the worldwide standard in the co-development and production of scalable and reproducible
nanometer and micrometer scaffolds that enable scientists to develop medical implants helping the
human body to repair itself, such as heart valves, blood vessels, nerves, tendons, skin and bone. IME
operates a brand new high-end GMP Laboratory and set of cleanrooms. With this the company is able
to not only develop and manufacture its top-end proprietary electrospinning machines, but to also
produce the actual scaffolds for the intended medical implants for their customers. The cleanroom
facilities enable the production of Class I, II and III medical devices.
Recente reacties